000 01549 a2200385 4500
005 20250516013123.0
264 0 _c20110321
008 201103s 0 0 eng d
022 _a1478-3231
024 7 _a10.1111/j.1478-3231.2010.02376.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNorthup, Patrick G
245 0 0 _aAnticoagulation in cirrhosis patients: what don't we know?
_h[electronic resource]
260 _bLiver international : official journal of the International Association for the Study of the Liver
_cJan 2011
300 _a4-6 p.
_bdigital
500 _aPublication Type: Comment; Editorial
650 0 4 _aAnticoagulants
_xadministration & dosage
650 0 4 _aAntithrombin III
_xmetabolism
650 0 4 _aBlood Coagulation
_xdrug effects
650 0 4 _aDrug Monitoring
_xmethods
650 0 4 _aEnoxaparin
_xadministration & dosage
650 0 4 _aEsophageal and Gastric Varices
_xblood
650 0 4 _aFactor Xa
_xmetabolism
650 0 4 _aFactor Xa Inhibitors
650 0 4 _aGastrointestinal Hemorrhage
_xchemically induced
650 0 4 _aHumans
650 0 4 _aLiver Cirrhosis
_xblood
650 0 4 _aLiver Function Tests
650 0 4 _aPredictive Value of Tests
650 0 4 _aRisk Assessment
650 0 4 _aSeverity of Illness Index
700 1 _aIntagliata, Nicolas M
773 0 _tLiver international : official journal of the International Association for the Study of the Liver
_gvol. 31
_gno. 1
_gp. 4-6
856 4 0 _uhttps://doi.org/10.1111/j.1478-3231.2010.02376.x
_zAvailable from publisher's website
999 _c20388312
_d20388312